Innoveren Scientific Inc. Stock Analysis IVRN
United States Health Care Nano Cap Innoveren Scientific, Inc. is a hybrid-biopharmaceutical company. The company is headquartered in Cincinnati, Ohio. The company went IPO on 2014-12-19. The firm is focused on advancing technologies in areas of unmet need across multiple indications for improving patient lives. Its product pipeline includes SkinDisc Lite, SkinDisc, and BreathEasy. From a single application, SkinDisc provides an active cellular matrix that maintains complete full wound contact and depth fill during the healing process, resulting in rapid growth of the host tissue. The SkinDisc product achieves healing in four to nine weeks. BreatheEasy is a 510(k) De Novo pathway medical device that is an autologous IV infusion that helps patients struggling with COPD, as well as other closely related diseases, such as chronic bronchitis and emphysema.
Read More Innoveren Scientific Inc (IVRN) Chart
Key Statistics of Innoveren Scientific Inc (IVRN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
704.00P/E Ratio (TTM)
-52 Week Range
Market Cap
1297.60Avg. Volume
704.00Dividend Yield
-Financial Metrics & Statements of Innoveren Scientific Inc (IVRN)
FAQ's for Innoveren Scientific Inc (IVRN)
- According to Musaffa’s Shariah screening methodology, Innoveren Scientific Inc (IVRN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.